Confidential information has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted information denoted by “[ * ]” on one page of this exhibit. SUBSCRIPTION...Subscription Agreement • March 19th, 2021 • BT DE Investments Inc. • Pharmaceutical preparations • Ontario
This SUBSCRIPTION AGREEMENT dated March 10, 2021 (this “Agreement”) is made by and between BT DE Investments Inc., a corporation existing under the Laws of the State of Delaware (the “Purchaser”), and Organigram Holdings Inc., a corporation existing under the Act (the “Company”).
Confidential information has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted information denoted by “[ * ]” on six pages of this exhibit. INVESTOR...Investor Rights Agreement • March 19th, 2021 • BT DE Investments Inc. • Pharmaceutical preparations • Ontario
This INVESTOR RIGHTS AGREEMENT dated March 10, 2021 (this “Agreement”) is made by and between BT DE Investments Inc., a corporation existing under the Laws of the State of Delaware (the “BAT Shareholder”), and Organigram Holdings Inc., a corporation existing under the Act (the “Company”).
Joint Filing AgreementJoint Filing Agreement • March 19th, 2021 • BT DE Investments Inc. • Pharmaceutical preparations
This JOINT FILING AGREEMENT, dated as of March 19, 2021, is between BT DE Investments Inc. and British American Tobacco p.l.c. (together, the “Joint Filers”).
